In the CNS, altered PDE4 activity has been linked to neuropsychiatric disorders, while PDE5 dysfunction is implicated in neurodegenerative conditions such as Alzheimer’s disease and cerebrovascular disorders like stroke [3,27,28]. This evidence concerns the gene PDE4A and Alzheimer disease.